Status:

ACTIVE_NOT_RECRUITING

Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Geriatric

Haematologic Neoplasm

Eligibility:

All Genders

65+ years

Brief Summary

The aim of this study is to implement a simple and unsupervised home-based physical activity (PA) program for cancer patients in 2 oncogeriatric units in Toulouse Hospital (day hospital and week hospi...

Detailed Description

Cancer treatments can cause side effects such as fatigue and reduced muscle function. Studies have shown the benefits of physical activity, including reduced fatigue and improved quality of life. More...

Eligibility Criteria

Inclusion

  • inclusion criteria:
  • suffering from a hematological malignancy (Myelodysplasia, Leukemia of any type, Lymphoma, Myeloma)
  • patient affiliated to a social security insurance
  • Patient undergoing or scheduled chemotherapy (\< 3 months) and/or immunotherapy and/or targeted therapy.
  • Exclusion criteria:
  • Life expectancy estimated at less than 3 months by the unit doctor;
  • Cognitive impairment (not allowing comprehension of the physical activity program and research project) defined by Mini-Mental State Examination (MMSE) \<20/30;
  • Patient included in a clinical trial that potentially interferes with the study objective (geriatric interventional study, early drug study, study modifying the patient's lifestyle habits).;
  • Acute health problem (fever, severe anemia, intense pain, etc.) limiting the possibility of involvement in the program;
  • Contraindication to physical activity;
  • Patient under legal protection (guardianship or curatorship or safeguard of justice);
  • Refusal of patient or primary caregiver to participate.

Exclusion

    Key Trial Info

    Start Date :

    November 14 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2025

    Estimated Enrollment :

    69 Patients enrolled

    Trial Details

    Trial ID

    NCT06102876

    Start Date

    November 14 2023

    End Date

    September 30 2025

    Last Update

    April 10 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Chu de Toulouse

    Toulouse, France